Abstract
Medical care is increasingly evolving towards patient-centered medicine, which is at the heart of the value-based healthcare (VBHC) model. The VBHC model simultaneously prioritizes better health outcomes while optimizing costs. Its application therefore requires the use of quantitative indicators to assess the performance of healthcare systems. At the same time, in glaucoma, minimally invasive procedures are expanding therapeutic options, gaining popularity and establishing themselves as an attractive alternative to traditional, riskier glaucoma surgeries. These safer procedures are increasingly enabling early intervention in the care pathway of glaucoma patients. However, their cost-effectiveness remains to be determined. This work aims to analyze the impact of the current approach to glaucoma management through the VBHC model and to discuss performance indicators that allow for effective evaluation.